RxDoctor Payments DataLook up a doctor →

Angela Garrard

Psychiatric/Mental Health · Gadsden, ALNPI 1770981458

Payments from drug & device makers

$14,489in general payments, 2019–2025

Across 925 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • AbbVie$1K
  • Alkermes, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • Tris Pharma Inc$1K
  • plus $5K from 20 others

What the payments were for

  • Food & beverage$14,40899%
  • Education$811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,489 in reported general payments places this provider in the 95th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate23$38,505
Abilify MaintenaAripiprazole11$34,372
RexultiBrexpiprazole14$19,822
Trazodone Hcl98$2,569
Divalproex Sodium ErDivalproex Sodium25$2,145
Methylphenidate ErMethylphenidate Hcl12$1,985
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine53$1,505
Aripiprazole47$1,486
Olanzapine54$1,329
Duloxetine Hcl38$1,248
Risperidone56$1,207
Ziprasidone Hcl17$893
Bupropion XlBupropion Hcl31$879
Venlafaxine Hcl ErVenlafaxine Hcl27$784
Clonazepam73$651

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$1,273$54,19425 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$2,125$38,50523 claims
Almatica Pharma LLCSertraline Hcl$151$31323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Gadsden

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →